Evaluating Single-Stage Laparoscopic Cholecystectomy with Intraoperative ERCP for Cholecystocholedocholithiasis


Introduction: The management of concomitant cholelithiasis and choledocholithiasis remains complex. While laparoscopic cholecystectomy (LC) is the gold standard for gallstones, addressing common bile duct (CBD) stones requires additional intervention. Single-session LC with intraoperative endoscopic retrograde cholangiopancreatography (ERCP) offers cost-effectiveness, patient convenience, and low complication rates, and has emerged as a promising alternative to traditional two-stage management. Objective: To evaluate clinical outcomes of single-session LC combined with intraoperative ERCP in patients with cholecystocholedocholithiasis. Methods: A retrospective study was conducted on 42 patients undergoing single-session LC with ERCP at a tertiary care center from January 2022 to December 2023. Data was recorded prospectively. Primary outcomes included CBD clearance rates, complications, operative time, hospital stay, and need for re-intervention. Results: Of 42 patients (23 males, 19 females; mean age 47.3 ± 14.2 years), CBD clearance was achieved in 95%. Median operative time was 180 minutes (IQR: 135–240). No major postoperative complications were recorded. ERCP failed to clear stones in 2 cases. Three patients required conversion to open surgery. Mean postoperative hospital stay was 2 days (range: 1–4). Five patients required reintervention during follow-up. Conclusion: Single-session LC with intraoperative ERCP is a safe and effective approach for managing cholecystocholedocholithiasis. It achieves high clearance rates with minimal morbidity and reduced hospital stay. Broader adoption is encouraged in centers equipped with the necessary expertise and facilities.
PDF